Corrective Phases R...
Health Care: Health Services
Baxter International Inc. (BAX: NYSE)
$50.06 -0.11 | -0.22%
06/04/12 - 04:01 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 50.17 |
| 52 Week High | 62.50 |
| 52 Week Low | 47.55 |
| Avg. Daily Vol. (Mil) | 2.80 |
| Beta (3 year) | 0.76 |
| Share Related Items | |
| Mkt Cap (Mil) | 27,910.97 |
| Shares Out (Mil) | 556.33 |
| Float (Mil) | 495.51 |
| Dividend Information | |
| Yield % | 2.70 |
| Annual Dividend | 1.34 |
| Payout Ratio | 33.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 1.70 |
| LT Debt/ Equity | 0.66 |
| Total Debt / Equity | 0.77 |
| Valuation Ratios | |
| Price Earnings | 12.70 |
| Price/Sales | 1.99 |
| Price/Book | 4.15 |
| Price/Cash Flow | 9.50 |
| Per Share Data | |
| Earnings | 3.94 |
| Sales | 25.16 |
| Book Value | 12.09 |
| Cash Flow | 5.26 |
| Business Summary | |
|---|---|
| Baxter International Inc, is a healthcare Company, which develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic. | |
| General Information | |
| One Baxter Parkway
Deerfield, IL 60015 |
|
| www.baxter.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 48500 | |
| CEO: Robert L. Parkinson,Jr | |
| Short Interest | |
| Current Month (Mil) | 4.51 |
| Previous Month (Mil) | 3.99 |
| Short Interest Ratio (Days) | 1.30 |
| Management Effectiveness | |
| Return on Equity | 33.30 |
| Return on Assets | 11.90 |
| Return on Investments | 20.10 |
| Profitability | |
| Gross Margin | 55.50 |
| EBIT Margin | 20.70 |
| Profit Margin | 16.00 |
Portfolios with BAX
- Portfolio NameUser Type
- ProJohn Paulson
- ContributorMost-Searched Stocks for th...
- ContributorTop-Yielding Health Service...
- ProBill Frels - Mairs & Power
- ProHighbridge Capital Management
- ProFarallon Capital Management
- UserDividend Income 2011-11-23
- ProJohn Buckingham - Al Frank ...
- ContributorDividend Stocks for the Wee...
- Contributor9 Stocks With Low Volatilit...
Latest BAX Headlines from TheStreet
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 05.25.12 | 05:05 pm
- 6 Low-Yield Dividend Captures 05.18.12 | 11:05 am
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 05.11.12 | 04:05 pm
- 'Mad Money' Lightning Round: Devon's Worth More 04.19.12 | 07:04 pm
- Baxter International's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.19.12 | 02:04 pm
- NYSE Stocks Posting Largest Percentage Decreases 04.16.12 | 06:04 pm
- Mattel, Endocyte, Ivanhoe Are Market Movers 04.16.12 | 05:04 pm
- 7 Hot Stocks on Traders' Radars 04.16.12 | 03:04 pm
- NYSE Stocks Posting Largest Percentage Decreases 04.16.12 | 01:04 pm
- 'Mad Money' Lightning Round: Bullish on Baxter 03.27.12 | 07:03 pm
Press Releases for BAX
- Baxter Announces Collaboration With Chatham Therapeutics For Factor IX Hemophilia B Gene Therapy Treatment - Business Wire 06.04.12 | 09:06 am
- Baxter To Present At William Blair & Company 32nd Annual Growth Stock Conference - Business Wire 05.30.12 | 04:05 pm
- Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control In Trials Of Diabetics Undergoing Dialysis - Business Wire 05.25.12 | 03:05 am
- Baxter To Present At Goldman Sachs 33rd Annual Global Healthcare Conference - Business Wire 05.23.12 | 04:05 pm
- Baxter Announces ADVATE Approval In China For The Treatment Of Hemophilia A - Business Wire 05.16.12 | 09:05 am
- Baxter Declares Quarterly Dividend - Business Wire 05.07.12 | 04:05 pm
- Baxter To Present At Bank Of America Merrill Lynch 2012 Healthcare Conference - Business Wire 05.02.12 | 04:05 pm
- Leading Health Economist Mark V. Pauly, Ph.D., Named 2012 Recipient Of The Willam B. Graham Prize For Health Services Research - Business Wire 05.01.12 | 09:05 am
- Baxter Completes Purchase Of Sigma International - Business Wire 04.26.12 | 08:04 am
- Baxter To Present At Deutsche Bank Securities, Inc. 37th Annual Healthcare Conference - Business Wire 04.24.12 | 04:04 pm
Partner Headlines for BAX
- Baxter And Neostem Validating Each Other's Cell Therapies - Seeking Alpha 06.01.12 | 09:06 am
- Stock Analysts Upgraded or Downgraded These Shares on Jun 1st - Wall St. Cheat Sheet 06.01.12 | 04:06 am
- UPDATE: Citi Lowers Baxter's PT - Benzinga 04.20.12 | 09:04 am
- Notable Options Activity in BAX - Benzinga 04.16.12 | 01:04 pm
- Baxter International Inc.: Worth A Look - Seeking Alpha 03.12.12 | 09:03 am
- Haemonetics Reaffirmed at Neutral - Analyst Blog - Zacks 03.02.12 | 06:03 pm
- Boston Scientific Offers Investors Huge Valuation Upside - Seeking Alpha 02.29.12 | 09:02 am
- Significant Upside Of About 25% For Baxter, Covidien - Seeking Alpha 02.24.12 | 05:02 pm
- Mylan Looks To Reap A Harvest Of Patent Expirations - Seeking Alpha 02.22.12 | 09:02 am
- Building A Capital Preservation And Income Portfolio, Part 8 - Seeking Alpha 02.17.12 | 04:02 pm
